Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-18-054013
Filing Date
2018-08-29
Accepted
2018-08-29 06:03:01
Documents
3
Period of Report
2018-08-01

Document Format Files

Seq Description Document Type Size
1 6-K a18-23003_16k.htm 6-K 15993
2 EX-99.1 a18-23003_1ex99d1.htm EX-99.1 14330
3 GRAPHIC g230031mmi001.jpg GRAPHIC 2108
  Complete submission text file 0001104659-18-054013.txt   34523
Mailing Address INDUSTRIEPARK ZQIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052
Business Address INDUSTRIEPARK ZQIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052 32 (9) 310 34 00
ARGENX SE (Filer) CIK: 0001697862 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38097 | Film No.: 181042892
SIC: 2836 Biological Products, (No Diagnostic Substances)